Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Case Reports in Immunology is Scopus-indexed (Q3, CiteScore 2.2), WoS ESCI, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2090-6609Verify ISSN ↗2090-6617Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 175 / 234 | 25th | Q3 |
| Immunology | 189 / 243 | 22nd | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present (also 2016–2017), best quartile Q3, CiteScore 2.2.
Case Reports in Immunology is Q3 in Immunology and Allergy (rank 175 of 234) and Q4 in Immunology (rank 189 of 243), by CiteScore 2025.
Case Reports in Immunology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q3 at the 25th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.261, quartile Q4, with an H-index of 8.
The publisher lists an article processing charge of about US$790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Case Reports in Immunology is published by John Wiley and Sons Ltd. Its print ISSN is 2090-6609 and its online ISSN is 2090-6617.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Case Reports in Immunology has an h-index of 16 and a 2-year mean of 0.91 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q3. On 2-year citations it ranks #176 of 231 Scopus journals in Immunology and Allergy.
Case Reports in Immunology published 11 papers in 2025; its busiest recent year was 2021 with 14. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 74 research articles (2021–2026), authors are most often from United States (27.5%), Iran (11.3%) and Türkiye (6.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.